← back to database
JJDC is Johnson & Johnson’s corporate venture capital organization. It invests across pharmaceuticals and medtech at every stage, from new-company creation and seed through Series A, Series B and beyond, taking a long-term strategic approach to advancing healthcare innovations for patients.
Stage focus
Specialization
Generalist / Specialist
Specialist
Investing team
- Amir BlattPrincipal, Venture Investments
- Andres TellezPrincipal, New Company Creation
- Asish XavierVice President, Venture Investments
- Biren MehtaVice President, Venture Investments
- Chris PicarielloPresident, JJDC
- Christine BrennanVice President, Venture Investments
- Edna LazarPrincipal, Venture Investments
- Fiona MacLaughlinVice President, Venture Investments
- Gilad GlickVice President, Venture Investments
- Hirak ParikhPrincipal, Venture Investments
- Lior TeitelbaumPrincipal, Venture Investments
- Nadiya IshnazarovaPrincipal, Venture Investments
- Rahul RakhitAnalyst, Venture Investments
- Shany SteinmetzAnalyst, Venture Investments
- Tamir MeiriPrincipal, Venture Investments
- V. Kadir KadhiresanVice President, Venture Investments
- Wei WuPrincipal, Venture Investments